121 related articles for article (PubMed ID: 370970)
21. Ultrastructure of the ileum in Crohn's disease. Immune lesions and mastocytosis.
Ranlöv P; Nielsen MH; Wanstrup J
Scand J Gastroenterol; 1972; 7(5):471-6. PubMed ID: 5070503
[No Abstract] [Full Text] [Related]
22. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
Theofilopoulos AN; Dixon FJ; Bokisch VA
J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
[TBL] [Abstract][Full Text] [Related]
23. Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines.
Yefenof E; Klein G; Jondal M; Oldstone MB
Int J Cancer; 1976 Jun; 17(6):693-700. PubMed ID: 181330
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
Gehlert T; Devergne O; Niedobitek G
J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
[TBL] [Abstract][Full Text] [Related]
25. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
[TBL] [Abstract][Full Text] [Related]
26. Unusual B cell morphology in inflammatory bowel disease.
Defendenti C; Grosso S; Atzeni F; Croce A; Senesi O; Saibeni S; Bollani S; Almasio PL; Bruno S; Sarzi-Puttini P
Pathol Res Pract; 2012 Jul; 208(7):387-91. PubMed ID: 22658383
[TBL] [Abstract][Full Text] [Related]
27. Immunopathology of Crohn's disease.
Brandtzaeg P
Ann Gastroenterol Hepatol (Paris); 1985; 21(4):202-20. PubMed ID: 3935037
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
[TBL] [Abstract][Full Text] [Related]
29. The subpopulations of circulating white blood cells in inflammatory bowel disease.
Thayer WR; Charland C; Field CE
Gastroenterology; 1976 Sep; 71(3):379-84. PubMed ID: 1084844
[TBL] [Abstract][Full Text] [Related]
30. Studies on Crohn's disease. II. Immunoglobulin-containing cells in the terminal ileum.
Persson S; Danielsson D
Acta Chir Scand; 1973; 139(8):735-8. PubMed ID: 4589010
[No Abstract] [Full Text] [Related]
31. Naive T cells in the gut of newly diagnosed, untreated adult patients with inflammatory bowel disease.
Horjus Talabur Horje CS; Middendorp S; van Koolwijk E; Roovers L; Groenen MJ; Wahab PJ; van Lochem EG
Inflamm Bowel Dis; 2014 Nov; 20(11):1902-9. PubMed ID: 25248006
[TBL] [Abstract][Full Text] [Related]
32. Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.
Raedler A; Fraenkel S; Klose G; Thiele HG
Clin Exp Immunol; 1985 Jun; 60(3):518-24. PubMed ID: 2990780
[TBL] [Abstract][Full Text] [Related]
33. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Kenney JS; Baumann R; Poindron P; Duclos B
Gut; 1996 Nov; 39(5):684-9. PubMed ID: 9026483
[TBL] [Abstract][Full Text] [Related]
34. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
[TBL] [Abstract][Full Text] [Related]
35. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease.
Marcussen H; Bendixen G
Scand J Gastroenterol; 1974; 9(2):149-52. PubMed ID: 4206480
[No Abstract] [Full Text] [Related]
36. Surface markers on canine lymphocytes.
Zander AR; Boopalam N; Epstein RB
Transplant Proc; 1975 Sep; 7(3):369-73. PubMed ID: 1099741
[No Abstract] [Full Text] [Related]
37. [Features of inflammation of the mucosa of the large intestine in nonspecific ulcerative colitis and Crohn's disease].
Novikova AV; Shcherbakov IT; Ol'shanskiĭ IaO; Iurkov MM; Levitan MKh
Arkh Patol; 1982; 44(9):31-9. PubMed ID: 6756359
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Baert FJ; D'Haens GR; Peeters M; Hiele MI; Schaible TF; Shealy D; Geboes K; Rutgeerts PJ
Gastroenterology; 1999 Jan; 116(1):22-8. PubMed ID: 9869598
[TBL] [Abstract][Full Text] [Related]
39. Complement receptor B lymphocytes in nodular sclerosing Hodgkin's disease.
Cossman J; Deegan MJ; Schnitzer B
Cancer; 1977 May; 39(5):2166-73. PubMed ID: 322853
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.
Middel P; Reich K; Polzien F; Blaschke V; Hemmerlein B; Herms J; Korabiowska M; Radzun HJ
Gut; 2001 Dec; 49(6):795-803. PubMed ID: 11709514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
